Aerovate Therapeutics Inc
AVTE
Market Cap$79.71M
Close$
$1.17
57.7% downside
Current Fair Value
57.7% downsideOvervalued by 57.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $79.71 Million |
|---|---|
| Enterprise Value | $46.37 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.44 |
| Beta | 0.95 |
| Outstanding Shares | 28,611,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.13 |
|---|---|
| PEG | 6.65 |
| Price to Sales | - |
| Price to Book Ratio | 1.38 |
| Enterprise Value to Revenue | 340.99 |
| Enterprise Value to EBIT | -0.51 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Aerovate Therapeutics Inc
2,021 employees